SCHEMBL8287253

SCHEMBL8287253

O=C(NC1CC1)c1cncc2c(=O)cc(Nc3ccccc3)n(-c3ccccc3)c12

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RIPK1 Q13546 1/20 0.43
MAPT P10636 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
CNR2 P34972 3/20 0.41
DPP4 P27487 1/20 0.39
DPP7 Q9UHL4 1/20 0.39
CNR1 P21554 2/20 0.39
HTR3E A5X5Y0 1/20 0.39
HTR3B O95264 1/20 0.39
HTR3A P46098 1/20 0.39
HTR3D Q70Z44 1/20 0.39
HTR3C Q8WXA8 1/20 0.39
NPC1 O15118 1/20 0.38
HTT P42858 1/20 0.38
RAB9A P51151 1/20 0.38
PDE4B Q07343 1/20 0.38
EGFR P00533 1/20 0.38
BTK Q06187 1/20 0.38
PIM1 P11309 1/20 0.37
PIM2 Q9P1W9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8287257 0.86 RAB9A (0.40) RIPK1MAPTNPC1HTTRAB9A
SCHEMBL8361774 0.85 RIPK1 (0.42) RIPK1CNR2CNR1NPC1PDE4B
SCHEMBL8287991 0.85 GAA (0.39) RIPK1MAPTNPC1RAB9A
SCHEMBL8360854 0.84 MAPK14 (0.38) MAPTNPC1HTTRAB9ANTRK1
SCHEMBL8360822 0.83 CSF1R (0.37) MAPTRXFP1CNR2MAPK14
SCHEMBL8362709 0.81 PDE11A (0.39) RIPK1MAPTDPP4HTTPOLB
SCHEMBL8287252 0.81 CXCR2 (0.37) RIPK1MAPTEGFRBTKNTRK1
SCHEMBL8287258 0.80 GRM5 (0.45) MAPTHTTPOLB
SCHEMBL8285215 0.78 CNR2 (0.44) RIPK1MAPTRXFP1CNR2CNR1
SCHEMBL8287968 0.78 RIPK1 (0.41) RIPK1MAPTRXFP1CNR2HTR3E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005091857-A2 1,6-NAPHTHYRIDINE AND 1,8-NAPHTHYRIDINE DERIVATIVES AND THEIR USE TO TREAT DIABETES AND RELATED DISORDERS BAYER PHARMACEUTICALS CORPORATION (US) 2005-10-06 WO disclosed
WO-2003027112-A1 1, 8-NAPHTHYRIDINE DERIVATIVES AS ANTIDIABETICS BAYER PHARMACEUTICALS CORPORATION (US) 2003-04-03 WO disclosed